In humans, IL-10 serum levels increase over time during CRC progression, correlating with poor prognosis [39,40,41,42], while high levels of ARG-1 were associated with stage III–IV CRC tumors and lymph node metastasis [43]. The gene discussed is IL10; the disease is metastatic malignant neoplasm in the lymph nodes.